Gert Laekeman

1.9k total citations
88 papers, 1.4k citations indexed

About

Gert Laekeman is a scholar working on Pharmacology, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Gert Laekeman has authored 88 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 14 papers in Geriatrics and Gerontology and 12 papers in Molecular Biology. Recurrent topics in Gert Laekeman's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Inflammatory mediators and NSAID effects (13 papers) and Mental Health Treatment and Access (6 papers). Gert Laekeman is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Inflammatory mediators and NSAID effects (13 papers) and Mental Health Treatment and Access (6 papers). Gert Laekeman collaborates with scholars based in Belgium, Türkiye and United States. Gert Laekeman's co-authors include Steven Simoens, A.G. Herman, Tim Smits, Veerle Foulon, Arnold Vlietinck, A. J. Vlietinck, Arnold G. Herman, A. G. Herman, Siska Desplenter and Simon Scharpé and has published in prestigious journals such as Kidney International, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Gert Laekeman

83 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gert Laekeman Belgium 23 316 312 228 174 168 88 1.4k
Carlos Pascual Spain 24 311 1.0× 139 0.4× 186 0.8× 57 0.3× 84 0.5× 95 2.1k
Isabel Vitória Figueiredo Portugal 21 326 1.0× 159 0.5× 167 0.7× 82 0.5× 100 0.6× 97 1.5k
Pietro Allegrini Italy 25 399 1.3× 209 0.7× 115 0.5× 181 1.0× 156 0.9× 69 1.9k
Mareni Rocha Farías Brazil 26 215 0.7× 194 0.6× 178 0.8× 50 0.3× 92 0.5× 82 1.6k
Joanna Harnett Australia 21 162 0.5× 174 0.6× 91 0.4× 97 0.6× 123 0.7× 110 1.3k
Marilyn K. Speedie United States 19 304 1.0× 221 0.7× 205 0.9× 146 0.8× 82 0.5× 75 1.1k
Workineh Shibeshi Ethiopia 23 150 0.5× 350 1.1× 104 0.5× 72 0.4× 162 1.0× 74 1.3k
Abdulrhman Alsayari Saudi Arabia 24 401 1.3× 184 0.6× 128 0.6× 103 0.6× 131 0.8× 105 1.8k
Grace m. Kuo United States 23 174 0.6× 157 0.5× 395 1.7× 131 0.8× 375 2.2× 61 1.7k
Eman Abu‐Gharbieh United Arab Emirates 20 292 0.9× 167 0.5× 154 0.7× 82 0.5× 108 0.6× 90 1.2k

Countries citing papers authored by Gert Laekeman

Since Specialization
Citations

This map shows the geographic impact of Gert Laekeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert Laekeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert Laekeman more than expected).

Fields of papers citing papers by Gert Laekeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gert Laekeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert Laekeman. The network helps show where Gert Laekeman may publish in the future.

Co-authorship network of co-authors of Gert Laekeman

This figure shows the co-authorship network connecting the top 25 collaborators of Gert Laekeman. A scholar is included among the top collaborators of Gert Laekeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gert Laekeman. Gert Laekeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Smits, Tim, et al.. (2013). Depression training involving consumer education: Impact on stigma toward people with depression. International Journal of Clinical Pharmacy. 35(3). 488–506. 3 indexed citations
3.
Smits, Tim, et al.. (2012). Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. International Journal of Clinical Pharmacy. 34(3). 452–459. 54 indexed citations
4.
Desplenter, Siska, Gert Laekeman, & Steven Simoens. (2011). Constraints and perspectives of pharmacists counseling patients with depression at hospital discharge. International Journal of Clinical Pharmacy. 33(1). 101–110. 5 indexed citations
5.
Peetermans, Willy, et al.. (2010). Antibiotic treatment of pneumonia in two different hospitals: results and opportunities for the clinical pharmacist. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 32(2). 298–299.
6.
Casteels, Minne, Marina Danckaerts, Jan De Lepeleire, et al.. (2010). Het toenemend gebruik van psychofarmaca. British Journal of Haematology. 130(5). 759–67. 1 indexed citations
7.
Desplenter, Siska, Gert Laekeman, Koen Demyttenaere, & Steven Simoens. (2009). Medication information for Flemish inpatients with major depression: evaluation and construct validity of the Consumer Information Rating Form. Journal of Clinical Pharmacy and Therapeutics. 34(6). 645–655. 6 indexed citations
8.
Desplenter, Siska, Steven Simoens, & Gert Laekeman. (2007). The impact of informing psychiatric patients about their medication: a systematic review. Pharmacy World & Science. 28(6). 329–341. 45 indexed citations
9.
Hoorens, Vera, et al.. (2006). The “extent of information desired”-scale in psychiatric in-patients: A behavioural approach. Patient Education and Counseling. 62(1). 72–78. 8 indexed citations
10.
Simoens, Steven, Jan Verhaegen, Gert Laekeman, & Willy Peetermans. (2005). Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development. International Journal of Antimicrobial Agents. 26(1). 62–68. 12 indexed citations
11.
Hoorens, Vera, et al.. (2005). Desire for information about drugs: a survey of the need for information in psychiatric in-patients. Pharmacy World & Science. 27(1). 47–53. 20 indexed citations
12.
Janssen, Lambert H.M., et al.. (2001). Cultivating the African plant Ajuga remota in Belgium and confirming its biological activity against Plasmodium falciparum. 6. 69–72. 2 indexed citations
13.
Laekeman, Gert, et al.. (1990). Effect of sulindac on renal blood-flow autoregulation in the rat. Kidney International. 37(1). 552–552. 2 indexed citations
14.
Janssens, Jos, Gert Laekeman, Luc Pieters, et al.. (1990). Nutmeg oil: Identification and quantitation of its most active constituents as inhibitors of platelet aggregation. Journal of Ethnopharmacology. 29(2). 179–188. 55 indexed citations
15.
Dam, Peter A. van, et al.. (1989). Prognostic value of prostaglandin F2 alpha concentrations in breast carcinoma.. Journal of Clinical Pathology. 42(10). 1046–1048. 1 indexed citations
16.
Laekeman, Gert, et al.. (1988). In Vitro Study of the Anticholinergic and Antihistaminic Activities of Protopine and Some Derivatives. Journal of Natural Products. 51(5). 1021–1022. 27 indexed citations
17.
Bult, Hidde, et al.. (1987). Hydroxy- and hydroperoxy derivatives of linoleic and arachidonic acid suppress the activation of rabbit blood platelets.. PubMed. 17A. 224–8. 4 indexed citations
18.
Vergote, I., et al.. (1985). Prostaglandin F2α in benign and malignant breast tumours. British Journal of Cancer. 51(6). 827–836. 31 indexed citations
19.
Verbeuren, T J, et al.. (1985). Effects of tertatolol on post- and prejunctional beta adrenoceptors.. Journal of Pharmacology and Experimental Therapeutics. 233(3). 801–809. 11 indexed citations
20.
Vandeplassche, G, et al.. (1984). Endotoxic shock in the piglet: beneficial effects of prostaglandin synthesis inhibition. Prostaglandins Leukotrienes and Medicine. 13(3). 271–278. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Pascual Breakdown of academic impact, for papers by Isabel Vitória Figueiredo Breakdown of academic impact, for papers by Pietro Allegrini Breakdown of academic impact, for papers by Mareni Rocha Farías Breakdown of academic impact, for papers by Joanna Harnett Breakdown of academic impact, for papers by Marilyn K. Speedie Breakdown of academic impact, for papers by Workineh Shibeshi Breakdown of academic impact, for papers by Abdulrhman Alsayari Breakdown of academic impact, for papers by Grace m. Kuo Breakdown of academic impact, for papers by Eman Abu‐Gharbieh
Rankless by CCL
2026